{"id":"https://openalex.org/W2183974727","doi":null,"title":"COMPARATIVE EVALUATION OF DISINTEGRANTS IN ORODISPERSIBLE TABLETS OF FAMOTIDINE","display_name":"COMPARATIVE EVALUATION OF DISINTEGRANTS IN ORODISPERSIBLE TABLETS OF FAMOTIDINE","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2183974727","mag":"2183974727"},"language":"en","primary_location":{"id":"mag:2183974727","doi":null,"is_oa":false,"landing_page_url":"http://www.ijcpr.org/Issues/Vol2Issue3/207.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5047263296","display_name":"Anish Chandy","orcid":"https://orcid.org/0000-0002-1481-4254","observed_orcids":["https://orcid.org/0000-0002-1481-4254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anish Chandy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1481-4254","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064483500","display_name":"Sandeep Gupta","orcid":"https://orcid.org/0000-0003-4905-9655","observed_orcids":["https://orcid.org/0000-0003-4905-9655"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandeep Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026132871","display_name":"Ashish Manigauha","orcid":"https://orcid.org/0000-0003-4122-2999","observed_orcids":["https://orcid.org/0000-0003-4122-2999"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashish Manigauha","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4122-2999","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5033412179","display_name":"Alok Singh Thakur","orcid":"https://orcid.org/0000-0003-1107-5537","observed_orcids":["https://orcid.org/0000-0003-1107-5537"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alok Singh Thakur","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1107-5537","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10615","display_name":"Granular flow and fluidized beds","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2206","display_name":"Computational Mechanics"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/famotidine","display_name":"famotidine","score":0.9340000152587891},{"id":"https://openalex.org/keywords/orally-disintegrating-tablets","display_name":"orally disintegrating tablets","score":0.9070000052452087},{"id":"https://openalex.org/keywords/disintegrants","display_name":"disintegrants","score":0.9580000042915344},{"id":"https://openalex.org/keywords/ac-di-sol","display_name":"Ac-Di-Sol","score":0.9599999785423279},{"id":"https://openalex.org/keywords/crospovidone","display_name":"crospovidone","score":0.9850000143051147},{"id":"https://openalex.org/keywords/sodium-starch-glycolate","display_name":"sodium starch glycolate","score":0.996999979019165},{"id":"https://openalex.org/keywords/tablet-disintegration","display_name":"tablet disintegration","score":0.7200000286102295},{"id":"https://openalex.org/keywords/wetting-time","display_name":"wetting time","score":0.7509999871253967},{"id":"https://openalex.org/keywords/in-vitro-drug-release","display_name":"in vitro drug release","score":0.7409999966621399},{"id":"https://openalex.org/keywords/tablet-hardness","display_name":"tablet hardness","score":0.8209999799728394},{"id":"https://openalex.org/keywords/drug-content-uniformity","display_name":"drug content uniformity","score":0.8450000286102295}],"concepts":[{"id":"https://openalex.org/C2781263782","wikidata":"https://www.wikidata.org/wiki/Q411159","display_name":"Famotidine","level":2,"score":0.6317196488380432},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35444772243499756},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.15730053186416626}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2183974727","doi":null,"is_oa":false,"landing_page_url":"http://www.ijcpr.org/Issues/Vol2Issue3/207.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1555994455","https://openalex.org/W1971295150","https://openalex.org/W1983521939","https://openalex.org/W2013561385","https://openalex.org/W2024345680","https://openalex.org/W2055975486","https://openalex.org/W2158962179","https://openalex.org/W2159269801","https://openalex.org/W2285569528"],"related_works":["https://openalex.org/W2965948699","https://openalex.org/W4290422063","https://openalex.org/W4407058776","https://openalex.org/W2379440531","https://openalex.org/W3002684702","https://openalex.org/W2355914191","https://openalex.org/W2261964480","https://openalex.org/W2189554673","https://openalex.org/W842536536","https://openalex.org/W2371060898"],"abstract_inverted_index":{"The\u00a0purpose\u00a0of\u00a0the\u00a0present\u00a0research\u00a0was\u00a0to\u00a0study\u00a0the\u00a0effect\u00a0of\u00a0using\u00a0variable\u00a0quantity\u00a0of\u00a0disintegrating\u00a0agents\u00a0like\u00a0Ac\u2010Di\u2010Sol,\u00a0Crospovidone,\u00a0Sodium":[0],"Starch\u00a0Glycolate":[1],"on\u00a0the\u00a0mouth\u00a0dissolving\u00a0property\u00a0of\u00a0Famotidine\u00a0tablets.\u00a0Total\u00a0nine\u00a0formulations\u00a0in\u00a0triplicate\u00a0having\u00a0disintegrants\u00a0at\u00a0variable":[2],"amount\u00a0were\u00a0prepared\u00a0by\u00a0direct\u00a0compression\u00a0method.\u00a0The\u00a0tablets,":[3],"were\u00a0assessed\u00a0if\u00a0suitable\u00a0as\u00a0oral\u00a0disintegrating\u00a0tablets\u00a0by\u00a0determination\u00a0of\u00a0a":[4],"range\u00a0of\u00a0technological\u00a0parameters.\u00a0It\u00a0was\u00a0observed\u00a0that\u00a0the\u00a0formulation\u00a0containing\u00a0Ac\u2010di\u00a0\u2010Sol\u00a0were\u00a0have\u00a0better\u00a0disintegrating\u00a0property\u00a0compared\u00a0to":[5],"other.\u00a0Hardness\u00a0of\u00a0the\u00a0tablets\u00a0was\u00a0found\u00a0to\u00a0be\u00a0in\u00a0the\u00a0range\u00a0of\u00a03.4\u20103.9\u00a0kg/cm2\u00a0for\u00a0all\u00a0formulations.\u00a0The\u00a0wetting\u00a0time\u00a0decreased\u00a0with\u00a0the\u00a0increase\u00a0in":[6],"concentration\u00a0of\u00a0disintegrants.\u00a0The\u00a0tablets\u00a0showed\u00a097.52\u00a0\u00b1\u00a00.46\u00a0%\u00a0to\u00a0100.56\u00a0\u00b1\u00a00.32\u00a0%\u00a0of\u00a0the\u00a0labeled\u00a0amount\u00a0of\u00a0drug,\u00a0indicating\u00a0uniformity\u00a0in\u00a0drug":[7],"content.\u00a0The\u00a0in\u00a0vitro\u00a0dissolution\u00a0time\u00a0of\u00a0various\u00a0formulations\u00a0was\u00a0between\u00a026.6\u00a0\u00b11.22\u00a0sec\u00a0to\u00a045.6\u00b12.57\u00a0sec.":[8]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}